Cargando…
EGFR in head and neck squamous cell carcinoma: exploring possibilities of novel drug combinations
Autores principales: | Rehmani, Hina S., Issaeva, Natalia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396252/ https://www.ncbi.nlm.nih.gov/pubmed/32793658 http://dx.doi.org/10.21037/atm.2020.04.07 |
Ejemplares similares
-
Advances in biomarkers and treatment strategies for HPV-associated head and neck cancer
por: Pan, Cassie, et al.
Publicado: (2018) -
EGFR Mutations in Head and Neck Squamous Cell Carcinoma
por: Nair, Sindhu, et al.
Publicado: (2022) -
Study of EGFR mutations in head and neck squamous cell carcinomas
por: Kaur, Gurpreet, et al.
Publicado: (2021) -
TRAF3/CYLD mutations identify a distinct subset of human papillomavirus‐associated head and neck squamous cell carcinoma
por: Hajek, Michael, et al.
Publicado: (2017) -
APOBEC-induced mutations and their cancer effect size in head and neck squamous cell carcinoma
por: Cannataro, Vincent L., et al.
Publicado: (2019)